PO susan bates 10/12N226 reimbursement for patient enrollment & testing services in phase II trial of depsipeptide(peter maccallum cancer centre)
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261200900005P
- Awardee
-
Peter Maccallum Cancer Institute UEI JXF6PDKH7UM8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $25,000
Award facts
- Contract value 100% obligated
- $25,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Australia
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN261200900005P?
HHSN261200900005P was awarded to Peter Maccallum Cancer Institute by National Cancer Institute (National Institutes of Health) on October 14, 2008.
How much is contract HHSN261200900005P worth?
The government has obligated $25,000 on HHSN261200900005P.
Which agency awarded contract HHSN261200900005P?
National Cancer Institute (National Institutes of Health) awarded HHSN261200900005P, with funding from Office of the Director (National Institutes of Health).
Was contract HHSN261200900005P competed?
The extent of competition for HHSN261200900005P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award